The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria

The American Journal of Medicine

Volumn 99, Issue 5, 1995, Pages 497-504

  Laffel, Lori M B ^a   McGill, Janet B ^b   Gans, Daniel J ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0028860451     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)80226-5     Document Type: Article

References (40)

1. Declining incidence of nephropathy in insulin-dependent diabetes mellitus
2. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus
3. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion
4. Predicting diabetic nephropathy in insulin-dependent patients
5. Incipient nephropathy in type 1 (insulin-dependent) diabetes
6. Microalbuminuria as a predictor of clinical diabetic nephropathy
7. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes
8. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
9. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
10. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
11. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
12. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis
13. Prevention of diabetic nephropathy with enalapril in normotensive insulin dependent diabetic patients with microalbuminuria
14. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria
15. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
16. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
17. Meta-analysis of effects of intensive blood glucose control on late complications of type I diabetes
18. Nonparametric Estimation from Incomplete Observations
19. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM
20. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy
21. Renal protective effect of enalapril in diabetic nephropathy
22. The case of intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
23. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
24. Short and long term effects of antihypertensive therapy in the diabetic rat
25. Dissociation between the course of the hemodynamic and antiproteinuria effects of angiotensin I converting enzyme inhibition
26. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria
27. Blood glucose control determines the renal hemodynamic response to angiotensin converting enzyme inhibition in type I diabetes
28. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus
29. Diabetic Renal Disease: the quest for normal tension-and beyond
30. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus
31. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?
32. Intensive therapy fails to prevent overt nephropathy in insulin dependent diabetics with microalbuminuria
33. Glycemic control does not predict progression from low to high microalbuminuria (MA) in insulin-dependent diabetes mellitus (IDDM)
34. The predictive value of microalbuminuria in IDDM
35. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration
36. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene
37. Relationships between Ang 1 converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
38. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus
39. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes mellitus and nephropathy